Jeffrey L. Deaton, M.D.  
     
     
Frequently Asked Questions
Frequently Asked Questions

Staff Information


REPRODUCTIVE MEDICINE STAFF: Paula Bauguess RN, Kelly Thompson MT (ASCP), Jeffrey L. Deaton, MD (seated), Angela Reagan BSN, Kristy Turner

RECEPTIONIST/SCHEDULER - Kristy Turner (336-841-7070)

Kristy will be scheduling many of your appointments and procedures. Kristy joined us in 2003.

NURSES (see photo under Fertility Drugs):

Paula Bauguess, R.N. has been with us since 1990. She does many of the ultrasounds and inseminations. She also calls many of the patients regarding their lab tests.

Carolyn Huffman, MSN, WHNP helps with the overall running of the center. She also assists with ultrasounds and inseminations when needed.

Angela Reagan, RN, BSN is our IVF nurse coordinator and has been with us since 2005. She oversees the running of the IVF program.

LABORATORY

Kelly Thompson, B.S., MT (ASCP) is the lab supervisor and has been with the team since 2004. She will be performing most of the lab procedures, including blood tests, sperm analyses, and insemination preparations.

We welcome you to our program. Our staff are extremely knowledgeable and we want you to feel comfortable asking us any question. Please feel free to discuss either any aspect of your treatment or other avenues such as adoption with us. Welcome!

Information about your Hysterosalpingogram


THE ABOVE PICTURE SHOWS A NORMAL HYSTEROSALPINGOGRAM. THE TRIANGULAR WHITE STRUCTURE IN THE CENTER REPRESENTS THE UTERINE CAVITY AND THE SMALL LINES ATTACHED TO THE UTERUS ARE THE TUBES.

1) CALL (336) 841-7070 WHEN YOUR PERIOD STARTS TO SCHEDULE THE PROCEDURE.



HYSTEROSALPINGOGRAM (x-ray of uterus and tubes)

A hysterosalpingogram is an x-ray study of the uterus and tubes. This particular test is used to determine if the tubes are open, or if they show signs of adhesions or blockages which could inhibit or prevent the fertilization process. The cavity of the uterus is also examined during this test. The hysterosalpingogram is a necessary step in determining the cause of your infertility, and can sometimes create a better atmosphere for conception.

The x-rays are viewed from several different angles after the uterus is filled with a clear contrast fluid, which is inserted into the cervix. The contrast agent shows up on an x-ray while being injected by your doctor. During and after the test, cramping may occur, and we recommend that you take 600-800 mgm of Ibuprofen (Advil, Nuprin, etc.) approximately one hour prior to the procedure.

When the uterus begins to fill, the contrast fluid will follow its path to the tubes and hopefully flow out the ends of the tubes. The contrast fluid ends up in the pelvis, is absorbed and disappears in time. If it does not flow through the tubes easily, then there could be a blockage of some kind. The blockage can be a result of an infection or some sort of scarring around the tubes, either of which can be interfering with the fertilization process.

Some side effects which MAY occur during or immediately after the procedure are cramping, nausea, or dizziness. These usually disappear within 30 minutes. For precautionary measures, it would be best to have someone with you to drive you home.

Semen Analysis Information and Scheduling


1. The semen specimen may be collected at home or in our collection room. If the specimen is collected at home, it must arrive at the laboratory within one hour of collection. Specimens should be collected into a sterile container with a screw-on lid. A sterile container can be obtained from our office or your family physician. The container must be placed in a ziplock bag for transport. All containers must be labeled with your name, wife's name physician, and date and time of collection.

2. The sample should be kept between room and body temperature (70-98.6 F). Do not heat or refrigerate the sample while transporting it to the laboratory. The sample must be delivered to the laboratory within one hour of collection for accurate results.

3. Please abstain from any ejaculation two days but no longer than seven days before your appointment. Abstinence for a longer or shorter period of time may affect the results. The preferred method of specimen collection is by masturbation. Do not use a condom or lubrication while obtaining the specimen. Most condoms contain a spermicide which will adversely affect semen quality.

4. Please bring a form of picture identification with you at the time of your scheduled appointment for identification verification.

5. The results of your semen analysis will be sent to your physician who will review the interpretation and recommendations with you. PLEASE DO NOT CALL THE LABORATORY FOR RESULTS AS WE CANNOT RELEASE THEM TO PATIENTS.

6. ALL TESTING REQUIRES AN APPOINTMENT.

SEMEN ANALYSES are performed most days except Thursdays, 8:30 a.m.-12:30 p.m. BY APPOINTMENT. The cost of the semen analysis is $110.00. Please call (336) 841-7070 to arrange an appointment.

ANTIBODY ANALYSES are performed BY APPOINTMENT. The cost of the antibody analysis is $200.00/patient. Please call (336) 841-7070 to arrange an appointment.

SEMEN CRYOPRESERVATIONS are performed Monday through Friday, 9:00 a.m.-12:00 noon BY APPOINTMENT. The charges for cryopreservation are $175.00 annual storage fee, $85.00 semen analysis/visit and $85.00 for semen cryopreservation. Please call (336) 841-7070 to arrange an appointment.

IVF WORK-UPS are performed BY APPOINTMENT. Refer to the IVF brochure for costs. Please call (336) 841-7070 to arrange an appointment as directed by the IVF nurse coordinator.


FEES ARE SUBJECT TO CHANGE
08/2006.

Fertility Drug Information (Gonadotropins)


NURSES: Paula Bauguess, Angela Reagan, and Carolyn Huffman


GONADOTROPINS FOR OVULATION INDUCTION

Gonadotropins include Follistim, Gonal-F, Repronex, Humegon, and Pergonal. Gonadotropins act directly on the ovaries and stimulate follicular (egg) development.

DESCRIPTION

HMG (Humegon, Repronex, Pergonal) is a mixture of follicle stimulating hormone (FSH) and luteinizing hormone (LH) in a 1:1 ratio and FSH (Follistim, Gonal-f) is a pure preparation of FSH. They are mostly packaged in snap-top ampules, but Humegon is dispensed in vials. HMGs are extracted from the urine of post-menopausal women, purified, and then freeze-dried into a powder, while the FSH preparations are made in the laboratory (recombinant). Before injection, gonadotropins must be reconstituted with diluent and then administered immediately by intramuscular injection or SC injection.

MODE OF ACTION

Gonadotropins act directly on the ovaries to stimulate the growth of follicles. Gonadotropins stimulate growth and maturation of follicles, but usually do not trigger ovulation (the release of the eggs). Therefore human chorionic gonadotropin (hCG) must be administered when the eggs are mature to mimic the hormonal surge that causes ovulation.

INDICATIONS

Gonadotropin therapy is indicated in the following situations:
1. Women who fail to ovulate or conceive after optimal doses of clomiphene citrate.
2. Couples with infertility and normal tubal anatomy who have failed simpler forms of therapy. In this situation it is often combined with intrauterine inseminations.

MONITORING AND ADMINISTRATION

Call with the first full flow day of your period, and take your weight prior to starting injections.

Monitoring the patient's response to gonadotropin therapy is essential in order to adjust dosage and to minimize the possibility of adverse reactions. A combination of both ultrasonography and estradiol measurements provides practitioners with an acceptable method of monitoring gonadotropin therapy. Estradiol is an indirect indicator of follicular maturity, while ultrasonography visualizes the number and size of developing follicles.

Estradiol monitoring is generally begun on day 4 or 5 after initiation of gonadotropin therapy and continued every day or every other day until the hCG injection. Estradiol levels are obtained in the morning and decisions about the next dose of therapy are made when the laboratory results are obtained in the afternoon. This facilitates gonadotropin dosage adjustments that afternoon or early evening. The timing of the hCG injection is based on both the size of the eggs and the estradiol level.

Sequential ultrasonography usually begins when estradiol levels reach 150 pg/ml or greater. Scans may or may not be done as frequently as estradiol monitoring, but every other day scans are necessary once a dominant follicle reaches a size of about 14 mm.

GONADOTROPIN DOSAGE

It should be given at about the same time each day--in either the late afternoon or early evening. This ensures accurate measurement of the patient's estradiol response. Blood for an estradiol level is best drawn 12 to 18 hours after the gonadotropin injection, making sure that the time interval is consistent day-to-day. If the estradiol level is below 2000 pg/ml and the dominant follicles are 16-18 mm, then the hCG dose can be given.

hCG DOSAGE AND ADMINISTRATION

Because most patients do not ovulate with gonadotropin treatment alone, ovulation is triggered with intramuscular injection of 10,000 U of hCG when the eggs are mature. This is usually administered 24 hours after the last gonadotropin injection. hCG acts like the LH surge and causes ovulation, which should occur about 36 hours after the injection. Other names for hCG are Pregnyl, Profasi and Novarel.

ADVERSE REACTIONS

Side effects associated with gonadotropin therapy include local irritation at the site of the injection and excessive ovarian stimulation (see below). Other reported side effects, such as dizziness, nausea, headaches, irritability and hot flashes, have been reported and may be associated with increased estrogen levels.

Applying warm, moist heat to irritated areas can provide relief to local irritation.

Improper injection techniques may result in injury or damage to the nerves. Therefore, it is important to review injection technique with your nurse and follow the injection instructions provided.

OVARIAN HYPERSTIMULATION

Mild to moderate uncomplicated ovarian hyperstimulation, which may be accompanied by abdominal distension and/or abdominal pain, occurs in approximately 20% of patients treated with gonadotropins and hCG. It generally regresses without treatment within two to three weeks. However, if a pregnancy occurs, it may persist several weeks into the pregnancy. Patients experiencing mild to moderate ovarian enlargement usually report pelvic fullness and some abdominal pain and discomfort, usually about four to ten days after administration of hCG. The degree of hyperstimulation is related to both the estradiol level and the number of eggs. Moderate or severe cases may need hospitalization (greater than 10 pounds weight gain).

If there is a concern about hyperstimulation, please follow the instructions below and report the following:

- weight gain of 5 lbs. or greater
- severe pelvic pain
- decrease in urine output

Also, refrain from the following:

- intercourse
- strenuous activity
- letting anyone perform a pelvic exam
- running/jumping type exercise

If your estradiol goes above 2000 and you develop many eggs, your cycle will be canceled due to the fear of severe hyperstimulation. If this happens, hCG will not be given and you may be placed on birth control pills.

MULTIPLE BIRTHS

The incidence of multiple gestation is approximately 30% and roughly 5% of all gonadotropin pregnancies results in triplets or greater. Multiple pregnancies can be complicated by premature delivery, hypertension and diabetes. If there is a significant concern of multiple births, then hCG and intercourse can be withheld.

MISCARRIAGE, CONGENITAL ANOMALIES

The incidence of miscarriage (15-25%) or congenital anomalies (2-5%) is felt to be no greater with gonadotropins than that found with spontaneous conceptions. However, taking 400 mcg (micrograms) of folic acid everyday has shown a decrease in neurotube defects in infants.

PREGNANCY RATE

Obviously, the pregnancy rate depends on the indication for gonadotropins.

1. The woman with irregular periods who has failed clomiphene citrate therapy and has no other cause for her infertility stands a roughly 25% chance of conception per cycle.

2. The couple with unexplained infertility or endometriosis stands a roughly 10-20% chance of conception per cycle.

If conception does not occur after four cycles of gonadotropins, you should meet with your physician.

COST

The expense of treatment includes:

- Gonadotropins ($50-55 per amp - 15 to 25 vials or amps/cycle)

- Ultrasounds ($200 per exam - 3 to 5 per cycle)

- Estradiols (3 to 5 per cycle)

Insurance may or may not pay for the gonadotropin treatment.

There is some concern that the use of ovulation induction agents may increase a person's risk of developing ovarian cancer. One in 424 women will develop ovarian cancer before the age of 40. There is, however, no conclusive evidence that the use of gonadotropins or hCG increases a woman's risk of ovarian cancer. Women with a history of infertility, independent of their use of gonadotropins or other ovulation induction agents, do have a higher incidence of ovarian cancer. Pregnancy and past use of oral contraceptives, appear to have a protective effect.

SCHEDULING IS AN ESSENTIAL PART OF THERAPY, BOTH FOR INJECTIONS AND FOR OFFICE VISITS, FOR SERUM ESTRADIOL LEVELS, ULTRASONOGRAPHY, AND POSSIBLY OTHER TESTS OR PROCEDURES.

Urine LH testing and inseminations


THE ABOVE PICTURE SHOWS HOW THE CATHETER IS PLACED DURING THE INSEMINATION. NOTICE THE UTERUS IS BETWEEN THE BLADDER AND THE RECTUM. FOR THE MAJORITY OF WOMEN, THE IUI INVOLVES EITHER NO PAIN OR MINIMAL CRAMPING.

1. Most inseminations are timed using an ultrasound. Our staff will give you instructions based on the ultrasound and tell you the day of the insemination.

INSTRUCTIONS FOR THE SEMEN SAMPLE

1. The semen specimen may be collected at home or in the collection room across the hall from the laboratory. If the specimen is collected at home, it needs to arrive at the lab within one hour of collection. The IUI specimen MUST be collected into a sterile, screwtop container which the lab will supply.

2. During transport, the container must be placed in a ziplock bag. All specimen containers brought in for IUI procedures must be labelled with the names of both partners, the physician, and the date and time of collection.

3. Keep the specimen between room and body temperature (70-98.6 degrees). Do not heat or refrigerate the specimen.

4. To obtain optimal semen specimens, it is recommended that an abstinence period of at least 1 day but not more than 5 days be observed. The specimen should be obtained by masturbation without the use of a condom or lubrication. Most condoms contain chemicals that kill the sperm.

5. Please bring a picture ID with you at the time of the scheduled procedure. The wife's ID will work if the husband is not going to be at the actual IUI.

6. For the very first IUI, make sure the appropriate consent forms have been signed by BOTH the husband and wife. If the husband will be at the first IUI, it can be signed at that time. Otherwise, arrange for it to be done ahead of time with a notarized signature. Consents are updated on an annual basis.

7. The IUI cannot be performed if the container is not appropriate OR if we do not have a current consent signed by both people.

8. If you have any questions regarding this procedure, please contact one of the staff at 336-841-7070 ahead of time. Thank you!

9. DONOR SPERM CAN BE OBTAINED FROM CRYOGENICS OR XYTEX (see web links on the home page). Please check with us for details.

Tubal surgery or IVF?


There are two options available to you if your tubes are tied. Please be aware that insurance companies often DO NOT COVER either approach.

TUBAL SURGERY

Depending on the type of tubal ligation you had performed, it may be possible to put your tubes back together. The following applies to tubal surgery:

1) If insurance does not pay for the procedure, you will need to pay $8,000 - $10,000 before the surgery is done.

2) The average success rate is 50-60% but may be somewhat higher or lower based on your condition. Many women do not get pregnant after the procedure.

3) The surgery involves an incision in your lower abdomen and you will need to stay in the hospital overnight. Most people need a 4-6 week recovery period.

4) If you get pregnant after the procedure, there is a 15-20% chance of a tubal pregnancy. These must be removed with either medicine or surgery.

5) We always perform a sperm count and a dye study of the uterus before the surgery.

6) If you come for an appointment to discuss the surgery, please bring a copy of your operative note (or have it faxed to us).

7) We rarely perform tubal surgery if the woman is over 39 years of age.

IN VITRO FERTILIZATION (IVF)

IVF is the method of choice if the sperm are abnormal or if a lot of tube was destroyed at the time of your tubal ligation. The following applies to IVF:

1) This is a non-surgical approach to getting pregnant if your tubes have been tied. It involves 4 steps:

a. Fertility shots to develop a lot of eggs.
b. Needle guided egg retrieval
c. Fertilization with sperm in a dish outside the body.
d. Transfer of embryos back into your uterus.

2) For costs, see the "IVF Information" link on the left side of the home page.

3) For the chance of a pregnancy, see "IVF Success Rates" on the left side of the home page. You may also want to check the other web links shown on the home page.

4) If you know for sure you want to do IVF, let the receptionist know when you call so the appropriate appointment can be made.

PROXIMAL TUBAL OCCLUSION

If your tubes were not tied but have a proximal blockage at the uterus, you may be a candidate for a TUBAL RECANALIZATION. This procedure is done in Radiology and uses xray to guide a wire into the start of your tube. An IV is placed and you are sedated during the procedure. The procedure is successful in opening up the tube in a majority of cases. It is a non surgical approach to opening up a tubal blockage at the junction of the uterus and tube. It can be performed by Dr. Ron Zagoria at the Wake Forest University Baptist Medical Center. The cost includes physician and hospital fees and totals $1,300.00 If you have any questions please feel free to contact us.

Ectopic Pregnancy


ECTOPIC PREGNANCY

In the majority of cases when a woman becomes pregnant, the fertilized egg attaches inside the woman's uterus and begins to grow. However, in about one in a hundred pregnancies, the fertilized egg begins to grow outside of the uterus. This is referred to as an ectopic pregnancy. The most common site of an ectopic pregnancy is in the fallopian tube. There are other sites where this can occur such as the ovary or the abdomen, but these are very rare. The symptoms of ectopic pregnancy often include the symptoms of pregnancy such as breast tenderness and/or nausea. Some women may not have any symptoms and may not even realize they are pregnant. Symptoms of an ectopic pregnancy may include abnormal vaginal bleeding, abdominal pain, shoulder pain, weakness, dizziness or fainting.

The diagnosis of ectopic pregnancy is often difficult to make. Special tests to confirm the diagnosis are often required. Blood pregnancy tests are performed. Often, special blood pregnancy tests called Beta-HCG are done on an interval basis to help distinguish a normal pregnancy from an abnormal pregnancy (ectopic or miscarriage). This particular test gives a numerical value. By repeating the test at frequent intervals and following the numerical value, it can be determined whether the ectopic pregnancy is resolving, getting worse, or staying the same. Transvaginal ultrasound is performed to aid in the diagnosis of ectopic pregnancy. Ultrasound involves the use of sound waves bouncing off internal organs and converting these to an image on a television screen. In some cases, laparoscopy is required to establish the diagnosis of ectopic pregnancy. In a laparoscopy, a special light-transmitting telescope is inserted through a small incision in your belly button to enable the gynecologist to visualize your fallopian tubes.

Because an ectopic pregnancy is outside the uterus, it cannot develop normally and usually must be treated. Because the fallopian tube is narrow and has a thin wall, pregnancies that wind up in the fallopian tubes can only grow to about the size of a walnut before the tube bursts. This can occur anytime during the first three months of pregnancy. Because the tube may burst and cause major bleeding in the abdomen or even death, tubal pregnancy must be treated promptly once diagnosed.

One treatment for an ectopic pregnancy is surgery. In surgery for an ectopic pregnancy, the ectopic pregnancy is removed from the fallopian tube. The exact procedure performed on the fallopian tube depends on how much damage the ectopic pregnancy has done. If there is minimal damage to the fallopian tube, then a small opening in the fallopian tube can be made, the ectopic pregnancy removed, and the tube allowed to heal (salpingostomy). If this type of surgery is performed, your pregnancy hormone level will be monitored on a weekly basis until negative. If the fallopian has undergone more extensive damage, that portion of the fallopian tube must be removed (salpingectomy). The above types of surgery on tubal pregnancies can usually be performed through laparoscopy.

There is available a newer treatment that does not involve surgery for selected patients with ectopic pregnancies. Not all patients with an ectopic pregnancy are eligible for this medical treatment. Criteria for medical therapy for ectopic pregnancies include: 1) that there be no evidence of excessive intra-abdominal bleeding (shock); 2) that the pregnancy be less than 1 1/2 inches (3.5 cm) in size based on either laparoscopy or ultrasound; 3) that the Beta-HCG values are not declining on their own; and, 4) there is no liver disease, blood disease, or kidney disease.

The name of the drug is Methotrexate. Methotrexate in large and frequent doses is used as a chemotherapy for some cancers. In small doses taken orally, it has also been used for rheumatoid arthritis and psoriasis. In the case of ectopic pregnancies, the dose administered is a moderate amount, as a single injection into the buttocks. The drug Methotrexate administered in this fashion stops growth of the pregnancy tissue and allows the body to absorb the pregnancy over time. Methotrexate only works when the pregnancy is small, the tube has not ruptured, and there is no excessive bleeding from the ectopic pregnancy. Careful follow-up over approximately one week is necessary for this form of therapy. Three days after the treatment, you will need to return to the lab for a repeat Beta-HCG. Then again on the seventh day following treatment, you will need to return to the lab for Beta-HCG repeat blood count and a liver enzyme test.

The chance of successful treatment after a single dose of Methotrexate is 95%. However, approximately 6% of patients will require surgery on their fallopian tube because the drug has not completely worked. As with any therapy, be it medical or surgical, there are side effects and complications. The overall rate of side effects and complications with Methotrexate is very low. This is less than the side effects and complications associated with surgery. The potential risks of Methotrexate are: irritation of the stomach, nausea, inflammation of the mouth, lips, tongue or gums, liver inflammation, reduced white blood cell count, and reduced blood platelet count. If these side effects occur (1%), they are temporary and usually resolve on their own without any further treatment.

Methotrexate may be less damaging to the fallopian tube than surgery in some patients. Approximately 85% of patients receiving Methotrexate for tubal pregnancy will have open tubes if a special x-ray called a hysterosalpingogram (HSG) is preformed after treatment. This is similar to and possibly better than the rate tubes remain open following most surgical procedures for ectopic pregnancies.

Following Methotrexate treatment, there are important precautions to take: First, you must not consume anything containing alcohol for one week. Second, you need to be at pelvic rest, including avoiding intercourse, until the ectopic pregnancy has fully resolved and a normal period has occurred. Third, it is important not to take any vitamin (including multi-vitamins) containing Folic Acid until the ectopic pregnancy has fully resolved and your Beta-HCG level is negative. Fourth, if your blood count is low (hematocrit less than 35), you will need to take Iron Sulfate (325 mgs.) twice a day for one month. Fifth, following the ectopic pregnancy, you will need to use either birth control pills or barrier methods of contraception (condoms, sponge, and/or diaphragm) for two months following the ectopic pregnancy in order to avoid getting pregnant and allowing the fallopian tube and uterus to fully heal.

The majority of patients develop an increase in abdominal/pelvic pain after Methotrexate treatment. This is generally relieved by Ibuprofen or Tylenol. If after your Methotrexate injection, you develop abdominal pain or pain that you had prior to the injection worsens, you will need to contact your gynecologist.

It is important for you to realize that as with any treatment for ectopic pregnancy, including surgery, there is about an 15% chance that, if you get pregnant in the future, the pregnancy would once again be an ectopic pregnancy. In the event that you get pregnant in the future, it is important to quickly verify whether or not you are pregnant by a pregnancy test, and then verify by means of an ultrasound that the pregnancy is in the uterus between 6 and 8 weeks after your last menstrual period. In the event that you develop abdominal pain, shoulder pain and/or vaginal bleeding, you will need to seek immediate medical attention to make sure that you do not have a repeat ectopic pregnancy.


METHOTREXATE FOR ECTOPIC PREGNANCY
PATIENT INSTRUCTIONS

1. Refrain from alcohol use, multivitamins containing folic acid, and sexual intercourse until hCG titer is negative. Limit sun exposure. Avoid gas-forming foods.

2. Call your physician if you experience prolonged or heavy vaginal bleeding.

3. You may experience mild lower abdominal or pelvic pain during the first 7-14 days of treatment. Call your physician if the pain is prolonged or severe. No pain medications, including over the counter medicines.

4. Make sure all your questions have been answered.

5. Approximately 6-10% of women experience unsuccessful methotrexate treatment and require surgery.

6. You will be seen following the methotrexate in 4 and 7 days. If the hCG (pregnancy hormone) titer is not decreasing appropriately, a second dose of methotrexate will be given. After the hormone level falls to low levels, you will be seen weekly until it is negative.


METHOTREXATE PROTOCOL FOR MEDICAL TREATMENT OF ECTOPIC PREGNANCIES OR PERSISTENT HCG LEVELS AFTER SURGICAL TREATMENT

DAY 1: Serum hCG, SGOT, CBC with diff, platelets. Give 1st Methotrexate shot (1 mg/kg IM)

DAY 4: Serum hCG

DAY 7: Same labs as day 1. Repeat dose if necessary (see below)

1. A transvaginal ultrasound must show no intrauterine gestational sac.
2. The hCG titer on day 4 may be higher than hCG on day 1 in the majority of patients.
3. If <15% decline in hCG titer between day 4 and 7, give second dose of methotrexate 1 mg/kg IM.
4. If >15% decline in hCG titer between day 4 and 7, follow hCG titers weekly until <5 mIU/ml.
5. If Rh-negative, give RhoGAM on day 1 or 2.
6. If HCT <35%, given FeSO4 325 mg b.i.d.

Contraindications to Methotrexate:

1. Transvaginal ultrasound demonstrating an ectopic pregnancy >3.5 cm in greatest dimension.
2. Hemodynamically unstable.
3. Significant abdominal pain.
4. Hepatic dysfunction: SGOT >2 X normal.
5. Blood dyscrasia: WBC <2,000 cells/cm3.
6. Thrombocytopenia (platelet count <100,000).
7. Renal disease: serum creatinine >1.5 mg/dl.
8. Cardiac activity in the ectopic pregnancy is a relative contraindication.

Precautions:

1. No intercourse
2. No pelvic exams
3. Limit sun exposure
4. No pain medication
5. No NSAID
6. Avoid gas forming foods

Risks:

Stomatitis (2-3%)
Increase liver function tests (6% transient)
Hemorrhage at site of tubal pregnancy (~6-10%)
Decrease blood count, platelets
Bloating
Gas pains


CONSENT FORM FOR METHOTREXATE TREATMENT

At the recommendation of my physician, I am requesting to be treated with Methotrexate as a medical alternative to either surgery or continued observation. I understand that this treatment consists of an injection of Methotrexate, a drug used in cancer, to kill pregnancy tissue for a maximum of four doses. Blood work will be monitored for any changes. This will consist of a blood count (CBC with diff, platelets) a test of liver function (SGOT), and the pregnancy hormone (hCG). Treatment will cease if a significant decrease in hCG levels occur. I will be seen after the methotrexate is given and hCG levels (pregnancy hormone) will be checked. If the hCG level is not going down, a second dose of methotrexate will be given and the pregnancy hormone levels followed. If the hCG level is falling to low levels, I will be seen weekly until the hormone level is negative.

I am aware that I need to observe the following precautions: no intercourse or pelvic exams; limit sun exposure; no pain medication or non-steroidal, anti-inflammatory drugs; avoid gas forming foods. I have been given written instructions and will comply with them.

Some of the risks that may occur include stomatitis (mouth ulcers) (2-3%), increase in liver function tests (6% transient), hemorrhage at site of ectopic pregnancy (6-10%) necessitating surgery, decrease in blood counts, platelets, bloating and gas pains.

Approximately 4-5% of patients do not respond to methotrexate and require surgery.

I understand that if during the treatment I should have any change in abdominal pain, feeling weak or faint, or increased vaginal bleeding, or have any problems that I feel are related to the treatment, I should contact my doctor.

I have read and understood this consent form. I understand that any questions that I may have had have been answered to my satisfaction. I also understand I may withdraw my consent at any time and choose an alternative approach to my problem.

Financial Information


Financial Information
Insurance coverage for infertility services varies greatly. Most health plans reimburse diagnostic services that enable the physician to determine the cause of your infertility but few plans reimburse treatment procedures such as intrauterine insemination (IUI) or in vitro fertilization (IVF).

Financial Counselor
Lois Solomon is the Premier Fertility Center Financial Counselor. She will meet/talk with you, discuss your current insurance coverage, and determine if a payment is necessary for the procedure(s) you will be having. Prior to your first appointment you will need to contact your health insurance carrier and determine if infertility benefits (diagnosis and treatment) are available to you.

Financial Policies
We would like to make you aware of our current financial policies regarding services performed at the Center. The Center participates with most health insurance plans. Please check with us to confirm we participate with your plan.

Covered Services
If the Center participates with your current insurance carrier(s) and the service performed is a covered benefit, we will accept the amount your carrier deems reasonable or allowable. If our charge is greater than the allowable amount determined by your insurance, as participating providers we will reduce our charge to the allowable amount. Your responsibility may be a co-payment (a fixed dollar amount per visit) or co-insurance (a percentage of the allowable amount). The Center requires all co-payments be made at the time of service. Otherwise you will be billed for co-insurance amounts.

Non Covered Services
If the Center determines any service is not covered by your insurance carrier you will be required to pay for those services when rendered. The Center also offers self-pay packages for IUI and IVF cycles that are not covered by insurance. The package amount includes all monitoring services and the treatment procedure. You will be billed for a single total amount instead of each service separately. The package amount will be calculated by Lois, will be due prior to the beginning of your treatment cycle and will be posted to our computer system when received. Non covered charges will not be submitted to your insurance. We will provide you with a receipt for the package amount.

Any outstanding balances must be paid in full prior to beginning treatment. Balances from prior treatment cycles must also be paid in full prior to beginning a new treatment cycle.

Payment Types
The Center accepts checks, cash, debit cards, Visa, MasterCard, or Discover.

Initial Visit
Some patients are enrolled in HMO?s (health maintenance organization) or POS (point of service) health insurance plans. If this applies to you, it is your responsibility to obtain the appropriate referral(s) for your initial visit from your primary care doctor. You will meet with Lois during your initial visit and review your current insurance coverage with her. After your initial appointment, Lois will investigate which future services need referral or pre-authorization.

Billing of Services
Infertility is a disease process that involves two individuals which complicates the billing of services rendered. The majority of infertility charges will be billed to the female. The male will be billed for all sperm related charges. It is important for you to review your health insurance coverage(s) since both of you will be billed for infertility services. The Center has created patient fee sheets that detail the costs of services and who those costs will be charged to. Lois can provide these to you.

Other Financial Considerations
Flexible Spending Benefits: Some employers allow employees to set aside a specified amount of your salary on a pretax basis for unreimbursed medical expenses. This allows you to pay your medical bills with pre-tax versus post-tax dollars. Check with your employer and determine if flexible spending benefits are offered to you or your spouse.

Income Tax Deduction: If your out-of pocket medical expense is high you may be able to deduct a portion of your medical bills on your income tax return. To do this you must be able to itemize deductions on your tax return and your medical expenses must exceed 7.5% of your adjusted gross income (AGI). Consult your tax advisor for details.
Home Equity Line of Credit ? HELOC: Refers to a loan in which the lender agrees to lend a maximum amount within an agreed period. HELOC loans have become very popular in the United States in recent years, in part because interest paid is typically (depending on specific circumstances) deductible under federal and many state income tax laws. This effectively reduces the cost of borrowing funds. Consult your banker and tax advisor for details.
Alternative Forms of Payment: Other payment options you may want to consider include using a credit card for medical payments. Some credit cards offer perks such as airline mileage, a percentage back of total charges or percentage discounts on automobiles or other services. Remember, however, you may not wish to pay with a credit card unless you can pay the balance in full before you incur finance charges.

QUESTIONS
If you have any questions regarding any of the above information please contact us at 336-841-7070. Thank you.

Treatment Costs


---INSEMINATION PACKAGES---

Oral Medication/IUI Package: $625
Gonadotropin/IUI Package: $1,150

Oral Meds/Donor Sperm Package $600
(does not include sperm bank charges)

---IVF PACKAGES---

Standard Premier IVF Package $7,000

Standard Premier IVF-ICSI Package $8,000

Other IVF Charges not Billed by Premier Fertility:

-----Anesthesia Fee: $200
-----IVF Medications (estimated) $3,500

Frozen Embryo Transfer Package: $2,150

Website Translation


Choose a language to translate this page!